within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01F_MacrolidesLincosamidesAndStreptogramins.J01FA02_Spiramycin;

model Spiramycin
  extends Pharmacolibrary.Drugs.ATC.J.J01FA02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>J01FA02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Spiramycin is a macrolide antibiotic used primarily to treat infections caused by susceptible bacteria. It is notably used for the treatment of toxoplasmosis, especially in pregnant women to prevent congenital transmission. Though used in several countries, it is not approved in the United States but remains in use in parts of Europe and other locations.</p><h4>Pharmacokinetics</h4><p>Typical pharmacokinetics in healthy adult volunteers, oral administration.</p><h4>References</h4><ol><li><p>Brook, I (1998). Pharmacodynamics and pharmacokinetics of spiramycin and their clinical significance. <i>Clinical pharmacokinetics</i> 34(4) 303–310. DOI:<a href=&quot;https://doi.org/10.2165/00003088-199834040-00003&quot;>10.2165/00003088-199834040-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9571302/&quot;>https://pubmed.ncbi.nlm.nih.gov/9571302</a></p></li><li><p>Frydman, AM, et al., &amp; Gaillot, J (1988). Pharmacokinetics of spiramycin in man. <i>The Journal of antimicrobial chemotherapy</i> 22 Suppl B 93–103. DOI:<a href=&quot;https://doi.org/10.1093/jac/22.supplement_b.93&quot;>10.1093/jac/22.supplement_b.93</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3182451/&quot;>https://pubmed.ncbi.nlm.nih.gov/3182451</a></p></li><li><p>Sutter, HM, et al., &amp; Warner, M (1992). Pharmacokinetics and bioavailability of spiramycin in pigs. <i>The Veterinary record</i> 130(23) 510–513. DOI:<a href=&quot;https://doi.org/10.1136/vr.130.23.510&quot;>10.1136/vr.130.23.510</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1641967/&quot;>https://pubmed.ncbi.nlm.nih.gov/1641967</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Spiramycin;
